| Title | Journal of Cancer Research and Therapeutics |
| Abbreviation | J. Cancer Res. Ther. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Medicine (miscellaneous) (Q3); Oncology (Q3); Radiology, Nuclear Medicine and Imaging (Q3) |
| h-index | 51 |
| Overall Rank/Ranking | 12365 |
| SCImago Journal Rank (SJR) | 0.427 |
| Impact Score | 1.31 |
| Publisher | Wolters Kluwer Medknow Publications |
| Country | India |
| ISSN | 09731482, 09741127 |
| Best Quartile | Q3 |
| Coverage History | 2005-2023 |
The Journal of Cancer Research and Therapeutics (JCRT), the official publication of Association of Radiation Oncologists of India (AROI). The JCRT, a quarterly publication, dedicated to basic and clinical sciences in oncology including radiation oncology.
Journal of Cancer Research and Therapeutics is a journal covering the technologies/fields/categories related to Medicine (miscellaneous) (Q3); Oncology (Q3); Radiology, Nuclear Medicine and Imaging (Q3). It is published by Wolters Kluwer Medknow Publications. The overall rank of Journal of Cancer Research and Therapeutics is 12365. According to SCImago Journal Rank (SJR), this journal is ranked 0.427. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 51. The best quartile for this journal is Q3.
The ISSN of Journal of Cancer Research and Therapeutics journal is 09731482, 09741127. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Journal of Cancer Research and Therapeutics is cited by a total of 1436 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Journal of Cancer Research and Therapeutics is 1.31, which is computed in 2024 as per its definition. Journal of Cancer Research and Therapeutics IF is increased by a factor of 0.07 and approximate percentage change is 5.65% when compared to preceding year 2022, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Journal of Cancer Research and Therapeutics is 1.31. If the same upward trend persists, Impact IF may rise in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 1.31 |
| 2022 | 1.24 |
| 2021 | 1.29 |
| 2020 | 1.51 |
| 2019 | 1.30 |
| 2018 | 1.37 |
| 2017 | 0.87 |
| 2016 | 0.85 |
| 2015 | 0.88 |
| 2014 | 0.96 |
Journal of Cancer Research and Therapeutics has an h-index of 51. It means 51 articles of this journal have more than 51 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Journal of Cancer Research and Therapeutics is 09731482, 09741127. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Journal of Cancer Research and Therapeutics is 12365. According to SCImago Journal Rank (SJR), this journal is ranked 0.427. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.427 |
| 2022 | 0.353 |
| 2021 | 0.363 |
| 2020 | 0.475 |
| 2019 | 0.461 |
| 2018 | 0.420 |
| 2017 | 0.400 |
| 2016 | 0.324 |
| 2015 | 0.372 |
| 2014 | 0.329 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 12365 |
| 2022 | 13621 |
| 2021 | 12982 |
| 2020 | 10521 |
| 2019 | 10539 |
| 2018 | 10932 |
| 2017 | 10956 |
| 2016 | 12817 |
| 2015 | 11513 |
| 2014 | 12196 |
Journal of Cancer Research and Therapeutics is published by Wolters Kluwer Medknow Publications. It's publishing house is located in India. Coverage history of this journal is as following: 2005-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Journal of Cancer Research and Therapeutics is J. Cancer Res. Ther.. This abbreviation ('J. Cancer Res. Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Medicine (miscellaneous) (Q3); Oncology (Q3); Radiology, Nuclear Medicine and Imaging (Q3), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Journal of Cancer Research and Therapeutics latest impact IF is 1.31. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 1.51 (2020) and 0.85 (2016), respectively, in the last 10 years. Moreover, its average IS is 1.16 in the previous 10 years.
The Journal of Cancer Research and Therapeutics has an SJR (SCImago Journal Rank) of 0.427, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 0.475 in 2020 and the lowest being 0.324 in 2016. Furthermore, the average SJR of the Journal of Cancer Research and Therapeutics over the previous 10-year period stands at 1.16.
The latest h-index of the Journal of Cancer Research and Therapeutics is 51.
The Journal of Cancer Research and Therapeutics is published by the Wolters Kluwer Medknow Publications, with its country of publication being the India.
The Journal of Cancer Research and Therapeutics is currently ranked 12365 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 10521 in 2020 and its lowest position of 13621 in 2022.
The standard ISO4 abbreviation for the Journal of Cancer Research and Therapeutics is J. Cancer Res. Ther..
Journal of Cancer Research and Therapeutics is classified as a journal that the Wolters Kluwer Medknow Publications publishes.
The Journal of Cancer Research and Therapeutics encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Journal of Cancer Research and Therapeutics is assigned the following International Standard Serial Numbers (ISSN): 09731482, 09741127.
The best quartile for the Journal of Cancer Research and Therapeutics is Q3 (2023).
The Journal of Cancer Research and Therapeutics coverage history can be summarized as follows: 2005-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Business: Theory and Practice | journal | 14643 | Vilnius Gediminas Technical University | 26 | 2.37 |
| European Union Politics | journal | 2569 | SAGE Publications Ltd | 75 | 3.24 |
| Historia | journal | 28724 | Universidade Estadual Paulista | 8 | 0.02 |
| Revue Francophone des Laboratoires (discontinued) | journal | 23244 | Elsevier Masson s.r.l. | 8 | 0.00 |
| Materials Research | journal | 15375 | Universidade Federal de Sao Carlos | 71 | 1.46 |
| World Englishes | journal | 3418 | Wiley-Blackwell | 64 | 1.64 |
| Syntax | journal | 3731 | Wiley-Blackwell Publishing Ltd | 33 | 0.93 |
| Proceedings of the Technical Association of the Graphic Arts, TAGA | conference and proceedings | 30903 | Technical Association of the Graphic | 8 | 0.00 |
| Indian Phytopathology | journal | 15501 | Springer Nature | 16 | 1.09 |
| Journal of Immigrant and Refugee Studies | journal | 8890 | Routledge | 36 | 2.04 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 1.31 |
| 2022 | 1.24 |
| 2021 | 1.29 |
| 2020 | 1.51 |
| 2019 | 1.30 |
| 2018 | 1.37 |
| 2017 | 0.87 |
| 2016 | 0.85 |
| 2015 | 0.88 |
| 2014 | 0.96 |
